Cash Flow ERIS Lifescience Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
431.00
404.00
442.00
394.00
331.00
317.00
Adjustment
254.00
139.00
49.00
44.00
44.00
30.00
Changes In working Capital
-98.00
-175.00
-29.00
5.00
-52.00
-53.00
Cash Flow after changes in Working Capital
586.00
368.00
461.00
443.00
322.00
294.00
Cash Flow from Operating Activities
486.00
291.00
378.00
375.00
271.00
223.00
Cash Flow from Investing Activities
-1,827.00
-974.00
-319.00
-323.00
123.00
-5.00
Cash Flow from Financing Activities
1,379.00
688.00
-44.00
-82.00
-334.00
-221.00
Net Cash Inflow / Outflow
38.00
5.00
13.00
-30.00
59.00
-3.00
Opening Cash & Cash Equivalents
56.00
50.00
36.00
67.00
7.00
10.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
94.00
56.00
50.00
36.00
67.00
7.00
Compare Cash Flow Results of ERIS Lifescience
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
431.24
2399.36
-1,968.00
-82.03%
Adjustment
254.26
212.2
42.00
19.82%
Changes In working Capital
-98.74
20.42
-118.00
-583.55%
Cash Flow after changes in Working Capital
586.76
2631.98
-2,045.00
-77.71%
Cash Flow from Operating Activities
486.01
2152.45
-1,666.00
-77.42%
Cash Flow from Investing Activities
-1827.56
-2080.52
253.00
12.16%
Cash Flow from Financing Activities
1379.78
5.27
1,374.00
26081.78%
Net Cash Inflow / Outflow
38.22
77.19
-39.00
-50.49%
Opening Cash & Cash Equivalents
56.02
304.82
-248.00
-81.62%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
94.25
382.01
-288.00
-75.33%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 66.59% vs -22.87% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
486.01
291.74
66.59%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
